No. 70 Smith & Nephew
Innovation Premium: 43.2%
Smith & Nephew in recent years has made major investments in R&D, spending $222 million in 2015 alone. Innovations at the British medtech giant include not only products but new business models, such as the Syncera system for bundling a total joint replacement episode. Syncera includes not only the implant systems but also digital services, performance reviews, and metrics.
[Image courtesy of Smith & Nephew]